← Leaderboards
Sonia Michael Najjar
Western University Of Health Sciences
$11,561,514
Attributed
$15,659,916
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,659,916 · 7
By mechanism
R01$15,559,116 · 6
R21$100,800 · 1
Top collaborators
- Vishwajeet Puri10 shared
- Theodore C Friedman6 shared
- Miklos Peterfy4 shared
Most similar at Western University Of Health Sciences
Same institution · by research overlap
- Miklos Peterfy$5,118,226
Others in their field
Top investigators on “Insulin”
- Jeffrey P Krischer · University Of South Florida$605,714,892
- John M Lachin · George Washington University$153,440,346
- David M Nathan · Massachusetts Institute Of Technology$139,041,931
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Mark A Magnuson · Vanderbilt University$79,749,111
- Jose A Luchsinger · Columbia University Health Sciences$71,267,462
Research focus
InsulinHyperinsulinismLiverHepaticMediatingInsulin ResistanceAdipose TissueExhibitsPathogenesisHepatocytePathway InteractionsObesityMetabolicDietGain Of FunctionNon-Insulin-Dependent Diabetes MellitusInsulin ReceptorMolecularFunctional DisorderImpairmentLipid BiosynthesisCellsPlayRegulation
Grant awards (44)
Novel Molecular Determinants of Insulin Clearance$477,742
R01 · FY2025 · DK
Novel Molecular Determinants of Insulin Clearance$458,632
R01 · FY2024 · DK
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics$564,499
R01 · FY2023 · MD · contact PI
Linking fat metabolism to hepatic fibrosis$515,670
R01 · FY2023 · DK · contact PI
Novel Molecular Determinants of Insulin Clearance$477,742
R01 · FY2023 · DK
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics$579,869
R01 · FY2022 · MD · contact PI
Linking fat metabolism to hepatic fibrosis$515,670
R01 · FY2022 · DK · contact PI
Novel Molecular Determinants of Insulin Clearance$487,992
R01 · FY2022 · DK
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics$676,255
R01 · FY2021 · MD · contact PI
Linking fat metabolism to hepatic fibrosis$515,670
R01 · FY2021 · DK · contact PI
CEACAM and Insulin Action$436,728
R01 · FY2021 · DK · contact PI
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics$704,221
R01 · FY2020 · MD · contact PI
Linking fat metabolism to hepatic fibrosis$521,106
R01 · FY2020 · DK · contact PI
CEACAM and Insulin Action$436,728
R01 · FY2020 · DK · contact PI
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics$613,874
R01 · FY2019 · MD · contact PI
CEACAM and Insulin Action$436,728
R01 · FY2019 · DK · contact PI
Novel pathways in the pathogenesis and pathophysiology of NAFLD in Hispanics$31,217
R01 · FY2019 · MD · contact PI
CEACAM and Insulin Action$436,728
R01 · FY2018 · DK · contact PI
CEACAM1: A link between metabolic and cardiovascular diseases$295,000
R01 · FY2016 · HL · contact PI
CEACAM1: A link between metabolic and cardiovascular diseases$80,416
R01 · FY2016 · HL · contact PI
CEACAM1: A link between metabolic and cardiovascular diseases$369,757
R01 · FY2015 · HL · contact PI
CEACAM1: A link between metabolic and cardiovascular diseases$367,852
R01 · FY2014 · HL · contact PI
CEACAM and Insulin Action$297,119
R01 · FY2014 · DK · contact PI
CEACAM and Insulin Action$25,000
R01 · FY2014 · DK · contact PI
CEACAM1: A link between metabolic and cardiovascular diseases$357,321
R01 · FY2013 · HL · contact PI
CEACAM and Insulin Action$310,844
R01 · FY2013 · DK · contact PI
CEACAM1: A link between metabolic and cardiovascular diseases$387,763
R01 · FY2012 · HL · contact PI
CEACAM and Insulin Action$322,119
R01 · FY2012 · DK · contact PI
CEACAM and Insulin Action$320,130
R01 · FY2011 · DK · contact PI
CEACAM and Insulin Action$453,335
R01 · FY2010 · DK · contact PI
Insulin resistance in the pathogenesis of NASH$374,500
R01 · FY2010 · DK · contact PI
Insulin resistance in the pathogenesis of NASH$374,500
R01 · FY2009 · DK · contact PI
CEACAM AND INSULIN ACTION$50,000
R01 · FY2009 · DK · contact PI
CEACAM AND INSULIN ACTION$303,167
R01 · FY2008 · DK · contact PI
CEACAM AND INSULIN ACTION$309,354
R01 · FY2007 · DK · contact PI
CEACAM AND INSULIN ACTION$318,593
R01 · FY2006 · DK · contact PI
CEACAM AND INSULIN ACTION$326,260
R01 · FY2005 · DK
SUBSTRATES AND INSULIN RECEPTOR ENDOCYTOSIS$31,033
R01 · FY2004 · DK
SUBSTRATES AND INSULIN RECEPTOR ENDOCYTOSIS$248,100
R01 · FY2003 · DK
SUBSTRATES AND INSULIN RECEPTOR ENDOCYTOSIS$240,875
R01 · FY2002 · DK
SUBSTRATES AND INSULIN RECEPTOR ENDOCYTOSIS$44,100
R01 · FY2002 · DK
SUBSTRATES AND INSULIN RECEPTOR ENDOCYTOSIS$233,859
R01 · FY2001 · DK
SUBSTRATES AND INSULIN RECEPTOR ENDOCYTOSIS$231,048
R01 · FY2000 · DK
INSULIN RECEPTOR SUBSTRATES AND LIPOGENESIS$100,800
R21 · FY2000 · DK